Search Results 671-680 of 18007 for Pathogens

1. A Study to Compare the Effectiveness and Safety of Emixustat Hydrochloride with Placebo to Treat Macular Atrophy Secondary to Stargadt Disease - Mayo Clinic

   If only one ABCA4 pathogenic mutation is identified or if two ABCA4 pathogenic mutations that typically occur on the same allele (ie, "in cis") are ...

2. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

   Stools known to be positive for ova and/or parasite(s), or other enteric pathogens (e.g., Salmonella, Shigella, and/or Campylobacter) within 28 days prior ...

3. Cystic fibrosis - Symptoms and causes - Mayo Clinic

   This condition, passed down in families, causes damage to the lungs, digestive system and other organs. Learn about screening and newer treatments.

4. Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea - Mayo Clinic

   Disease symptoms caused by a confirmed intestinal pathogen other than Clostridium difficile. Has a colostomy. Intraabdominal surgery within the last 60 days ...

5. As Commencement Approaches, Ph.D. Graduates Share The Path To Their Degree - News Archive

   In particular, the work showed the PD-1 molecule on Tfh cells is important in regulating pathogenic antibodies that cause anaphylaxis. Additionally, my ...

6. A Study of Adjunctive Ganaxolone Treatment in Children and Young Adults with CDKL5 Deficiency Disorder - Mayo Clinic

   (a) Molecular confirmation of a pathogenic or likely pathogenic CDKL5 variant, early onset, difficult to control seizures, and neurodevelopmental impairment are ...

7. A Study Of Severe Combined Immunodeficiency Disorders - Mayo Clinic

   ... pathogenic mutation(s) identified. Stratum C. SCID with Non-HCT Treatment Patients; Intention to treat with PEG-ADA or gene transfer with autologous modified ...

8. PKD1 Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Received genotyping result confirming a non-truncating pathogenic, likely pathogenic, or variant of uncertain significance (VUS) within a sub-region of PKD1 ...

9. zika - strategic response framework & joint operations plan

   In addition, the dynamics of Zika virus transmission —co-circulation with other pathogens, potential modes of transmission immune response, and potential ...

10. Publications - Erin E. Wiedmeier-Nutor, M.D., M.P.H. - Mayo Clinic

    Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma. Blood Neoplasia. 2025 Feb; 2 (1):100045 Epub 2024 Oct ...